{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-054479","form_type":"8-K","ticker":"DH","cik":"0001861795","company_name":"Definitive Healthcare Corp.","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.955987+00:00","generated_at":"2026-06-02T20:36:43.739023+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Definitive Healthcare Q1 revenue $63.5M (+7% YoY); Adj. EBITDA margin 32%; $20M buyback","bullets":["Revenue $63.5M, +7% YoY from $59.2M; net loss narrowed to $12.7M from $16.0M.","Adjusted Net Income $13.0M vs $9.1M; Adjusted EBITDA $20.0M (32% margin vs 26%).","Enterprise customers grew 6% YoY to 559; added 30 clients with >$100K ARR.","Board authorized $20M stock repurchase program through end of 2024.","FY2024 guidance: revenue $255-$261M (+1-4%); Q2 revenue $62-$63.5M (+2-4%)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-054479","json":"https://secwatch.observer/filing/0000950170-24-054479.json","markdown":"https://secwatch.observer/filing/0000950170-24-054479.md","text":"https://secwatch.observer/filing/0000950170-24-054479.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861795/000095017024054479/0000950170-24-054479-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861795/000095017024054479/dh-20240507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T20:36:43.739023+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7b14f6b5e22f73d2312c9568b643dbaa70da9363","claim":"Definitive Healthcare Corp. reported first quarter ended March 31, 2024 results: revenue $63.5 million, net income $(12.7) million.","evidence_excerpt":"EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2024 First quarter revenue grew 7% year-over-year to $63.5 million Framingham, MA (May 7, 2024) – Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence,","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861795/000095017024054479/0000950170-24-054479-index.htm","confidence":0.99,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"$63.5 million"},{"label":"Net income","value":"$(12.7) million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}